In our analysis of the immune function of PLK3 in gliomas, a positive association between PLK3 and T-cell immunity was found in regulatory T-cell differentiation and T-cell tolerance induction, both of which imply T-cell anergy and glioma aggressiveness [40]. The gene discussed is PLK3; the disease is glioma.